Fusion event
HBV-NAALADL2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Region type
S protein|Polymerase|large S protein|middle S protein|
Integrated sequence
AATCCTCACAATACCGCAGAGTCTAGACTCGTGGTGGACTTCTCTCAATTTTCTAGGGGGAACTACCGTGTGTCTTGGCCAAAATTCGCAGTCCCCAACC| |TCCAATCACTCACCAACCTCTTGTCCTCCAACTTGTCCTGGTTATCGCTGGATGTGTCTGCGGCGTTTTATCATCTTCCTCTTCATCCTGCTGCTATGCC
End
174250363/174532573 (Hg38)
Nearest miRNA
hsa-let-7g/Upstream/3425814; hsa-mir-1224/Downstream/836967;
Upstream sequence
agatggggtttctccatgttggtcaggctggtcttgaactcccagcctcagatgatcaacccacctcggcctcccaaagtgctgggattacaggtgtgag
Downstream sequence
TGCTTATAGAATAGTGAGGGAGAAAAAAATATAACTGGTTTCCCAAGCTACACTGAAGGAAAATTCGGTTGAGCCCCTGTTTCACTACCTGATCTATTCT
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.